Posted by Michael Wonder on 22 Sep 2024
Fruquintinib approved to treat adult patients with metastatic colorectal cancer
20 September 2024 - The MHRA has today approved the new medicine fruquintinib (Fruzaqla) to treat adult patients with metastatic colorectal cancer.
It is used when other treatments have not worked.
